Full name
PHOENIX PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.38.Z - Wholesale trade of other food products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.29.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
82.99.Z - Other business support activities, not elsewhere classified
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,6 | 2,3 | 3,5 | 53 |
EBITDA | 3,3 | 2,5 | 3,7 | 46,8 |
Short time liabilities | 23,7 | 37,8 | 41,8 | 10,4 |
Equity capital | 50,8 | 32,7 | 35,7 | 9,1 |
Operating profit (EBIT) | 1,3 | 0,7 | 2 | 196,5 |
Assets | 75,3 | 71,6 | 78,8 | 10,1 |
Net profit (loss) | 1,3 | 1,9 | 3 | 54,3 |
Cash | 8,3 | 10,8 | 15,6 | 44,9 |
Net income from sale | 136,6 | 165,3 | 175 | 5,9 |
Liabilities and provisions for liabilities | 24,6 | 38,9 | 43,2 | 10,8 |
Working assets | 65,9 | 63,2 | 71,1 | 12,5 |
Depreciation | 2,1 | 1,8 | 1,7 | -8,9 |
% | % | % | p.p. | |
Profitability of capital | 2,5 | 5,9 | 8,4 | 2,5 |
Equity capital to total assets | 67,4 | 45,6 | 45,3 | -0,3 |
Gross profit margin | 1,2 | 1,4 | 2 | 0,6 |
EBITDA Margin | 2,4 | 1,5 | 2,1 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 63 | 84 | 87 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane